|
On September 15, 1997, the United States Food and Drug Administration (FDA) announced that certain fenfluramine and dexfenfluramine manufacturers, including Wyeth-Ayerst Division of American Home Products and Interneuron Pharmaceuticals, would agree with the FDA's request for an emergency voluntary moratorium and recall of these products.
On September 12, 1997, the State of Florida Board of Medicine banned temporarily the prescription combination use of fenfluramine and phentermine.
Many physicians have recommended that medical monitoring be instituted on individuals who have taken these diet drugs because early intervention and treatment could significantly improve or cure their diseases. It is believed that many symptomatic and asymptomatic sufferers of valvular heart disease or pulmonary hypertension may discover their diseases too late for effective treatment.
On November 13, 1997 the FDA recommended that anyone who has used Fen-Phen or Redux undergo a medical examination even if they do not have any symptoms.
|
|
|
What Are These Diet Drugs? :
The combination use of Fenfluramine and phentermine and with dexfenfluramine is not approved by the United States Food and Drug Administration (FDA), but was not illegal when these drugs were on the market. Doctors are generally permitted to make "off-label" or non-approved uses of drugs if the drugs are approved for any use.
Symptoms Of Injury From Fen-Phen, Redux Or Pondimin Use:
Usually the first symptom of injury from these diet drugs is shortness of breath. Medically shortness of breath is called dyspnea
|
|
|
|
